What’s the deal with Alzheimer’s disease and amyloid?
For decades, scientists have concentrated on what now looks to be a blind alley.
Signal weather
Rising
Momentum is building quickly, so this card is a good early entry point into the topic.
At the end of last month, a scientific journal pulled a research paper on Alzheimer's disease. The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein called amyloid-β was responsible for memory loss in Alzheimer's disease. On its own, that might not seem notable; bad papers can make it through peer review and are only caught after publication. But this wasn't an isolated case. Over the past few years, multiple studies arguing that amyloid-β is the central driver of Alzheimer's disease have been retracted. Some scientists have even been indicted for fraud over the issue. All the while, none of the drugs targeting this protein and its pathway have had any real clinical effect. Read full article Comments
Stay on the signal
Follow What’s the deal with Alzheimer’s disease and amyloid?
Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.
Story map
Understand this topic fast
A quick entry into the story: why it matters now, who is involved, and where to go next for context.
Why it matters now
Topic constellation
Open the live map for this story
See which entities, story threads, sources, and follow-up articles shape this story right now.
Click nodes to continue
Entity pages
Story timeline
Continue with this story
A short sequence of events and follow-up stories to understand the arc quickly.
How reliable this looks
Signal and trust for Ars Technica
This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.
Reliability
92
Freshness
100
Sources in storyline
1
Related articles
More stories that share tags, source, or category context.
Lucasfilm drops The Mandalorian and Grogu final trailer at CinemaCon
"The old protect the young, and then the young protect the old."
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Intel refreshes non-Ultra Core CPUs with new silicon for the first time
For the first time in a while, the benefits of new Intel tech will trickle down.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
OpenAI starts offering a biology-tuned LLM
GPT-Rosalind is an LLM trained on biology workflows, available in closed access.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
As they got close to the Moon, Artemis II astronauts were eager to land
"If you had given us the keys to the lander, we would have taken it down."
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
More from Ars Technica
Fresh reporting and follow-up coverage from the same newsroom.
After a saga of broken promises, a European rover finally has a ride to Mars
Europe's first Mars rover mission is now on its fourth rocket: SpaceX's Falcon Heavy.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Lucasfilm drops The Mandalorian and Grogu final trailer at CinemaCon
"The old protect the young, and then the young protect the old."
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Intel refreshes non-Ultra Core CPUs with new silicon for the first time
For the first time in a while, the benefits of new Intel tech will trickle down.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
OpenAI starts offering a biology-tuned LLM
GPT-Rosalind is an LLM trained on biology workflows, available in closed access.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.